Rekhtman, Natasha <br/><br/>
Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Feb 2012 
 - 1167-76 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-11-2109  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--genetics<br/>Carcinoma, Squamous Cell--genetics<br/>Class I Phosphatidylinositol 3-Kinases<br/>ErbB Receptors--genetics<br/>Female<br/>Genotyping Techniques<br/>Humans<br/>Lung Neoplasms--genetics<br/>Male<br/>Middle Aged<br/>Mutation<br/>Neoplasm Staging<br/>Oncogenes<br/>Phosphatidylinositol 3-Kinases--genetics<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins c-akt--genetics<br/>Proto-Oncogene Proteins p21(ras)<br/>ras Proteins--genetics